This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US.

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in Wilmington, about 30 miles southwest of Philadelphia. Known as Merck Wilmington ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Merck is going all-in on domestic drug manufacturing with a $1 billion Delaware facility aimed at dodging Trump-era tariff ...

President Donald Trump has signed executive orders to relax some of his 25% tariffs on automobiles and auto parts, a ...

Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

Discover why Dassault Systemes (DASTY) faces a hold rating amid macro uncertainties and deal risks, despite strong ...

The U.S. and Ukraine have announced an economic deal after a weekslong press by President Donald Trump calling on Kyiv to compensate Washington for billions more in military and economic assistance to ...